View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down Syndrome B Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
  • Protocol ID
    AALL1731
  • Disease
    Disease Type Disease Subtype
    Leukaemia
    ALL
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Queensland Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 3
  • Study type
    Treatment
  • Diagnosis stage
    New diagnosis
  • Study open date
    15/10/2019
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Children's Oncology Group
Back to search results